Actionable mutations in multiple genes (e.g., EGFR, PTEN, ESR1, IDH1, ERBB2, and FGFR2) and longitudinal changes in MAFs following surgical treatment have been detected in cfNA present in CSF of GBM and BM patients [74]. This evidence concerns the gene EGFR and glioblastoma.